This New Antibody Drug Could Slow Down Cancer

PRL3-zumab, an antibody drug targeting a protein in cancer cells, has shown safety and efficacy in clinical trials.

Supporting Safe And Efficient Work With cPass™ Testing

GenScript’s cPass serology test helped one construction firm, AcroMeta Group, ensure employees could make informed decisions on their individual COVID-19 risk and prevention.

Key Antibody Targets Of SARS-CoV-2 Identified

Researchers in Hong Kong have discovered that focusing on antibodies against ORF3b and ORF8 could lead to a rapid antibody test that is both highly sensitive and specific.

Test Detects SARS-CoV-2 Neutralizing Antibodies In Hours

Not only is it much faster than conventional tests, it does not need to be performed in special biosafety laboratories.

Protective Antibodies Against COVID-19 Isolated & Characterized

Potent neutralizing antibodies from COVID-19 patients have been isolated and characterized in two separate studies from China.

A*STAR’s Chief Scientist On COVID-19 Immunity And Antibody Drugs (VIDEO)

Catch Sir David Lane, A*STAR’s Chief Scientist and leading antibody expert, in our upcoming Wildtype Media Expert Opinion webinar.

Advancing Antibody Research

Powerful antibody engineering technologies and a culture of collaboration set Chugai Pharmabody Research apart, says CEO Dr. Tomoyuki Igawa.

‘Frankenbodies’ Light Up Live Cells

A research group in Japan has created hybrid antibodies that can bind to and label specific targets in living cells.

Neutralizing Antibody Shields Mice From Zika Virus

A single injection of a human neutralizing antibody is enough to protect developing mouse embryos against Zika virus infection and microcephaly, researchers say.

Universal Antibody Drug Against HIV Developed

Hong Kong scientists have developed a bispecific antibody that ‘kills two birds with one stone’ and can neutralize virtually all known strains of HIV.